Rockville's Supernus Pharmaceuticals wins patents dispute trial

This is the second patent infringement case Supernus has faced to its epilepsy drug Oxtellar.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.